FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 319 | -96.6% | 0.00% | – |
Q2 2023 | $44 | -24.1% | 9,441 | -8.7% | 0.00% | – |
Q1 2023 | $58 | +286.7% | 10,336 | +587.2% | 0.00% | – |
Q4 2022 | $15 | -100.0% | 1,504 | +10.2% | 0.00% | – |
Q3 2022 | $30,000 | +650.0% | 1,365 | +689.0% | 0.00% | – |
Q2 2022 | $4,000 | -99.0% | 173 | -98.3% | 0.00% | – |
Q1 2022 | $403,000 | +1579.2% | 10,417 | +2345.3% | 0.00% | – |
Q4 2021 | $24,000 | -96.9% | 426 | -97.8% | 0.00% | -100.0% |
Q3 2020 | $770,000 | +2466.7% | 19,284 | +1121.3% | 0.00% | – |
Q4 2019 | $30,000 | -81.4% | 1,579 | -84.8% | 0.00% | – |
Q3 2019 | $161,000 | -25.8% | 10,388 | -3.2% | 0.00% | -100.0% |
Q2 2019 | $217,000 | -32.8% | 10,730 | -41.7% | 0.00% | 0.0% |
Q1 2019 | $323,000 | +201.9% | 18,413 | +119.4% | 0.00% | – |
Q4 2018 | $107,000 | +10600.0% | 8,394 | +7263.2% | 0.00% | – |
Q3 2018 | $1,000 | -99.3% | 114 | -99.1% | 0.00% | -100.0% |
Q2 2018 | $149,000 | -48.1% | 13,165 | -55.3% | 0.00% | -92.3% |
Q1 2018 | $287,000 | +1095.8% | 29,462 | +637.7% | 0.01% | +1200.0% |
Q4 2017 | $24,000 | – | 3,994 | +3740.4% | 0.00% | – |
Q3 2017 | $0 | – | 104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |